MFDS
- Status: likely_approved
🇰🇷 Scemblix in South Korea
Scemblix (ASCIMINIB) regulatory status in South Korea.
Marketing authorisation
Scemblix in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Scemblix approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Scemblix in South Korea?
Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.